Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism
- 1 July 1999
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 138 (1) , 39-44
- https://doi.org/10.1016/s0002-8703(99)70243-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Effectiveness and safety of bolus administration of alteplase in massive pulmonary embolismThe American Journal of Cardiology, 1992
- Thrombolysis using consecutive high dose bolus and infusion of alteplase in a patient with acute massive pulmonary embolismBlood Coagulation & Fibrinolysis, 1992
- Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trialJournal of the American College of Cardiology, 1992
- Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosisJournal of the American College of Cardiology, 1992
- Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: A European multicenter double-blind trialJournal of the American College of Cardiology, 1992
- RANDOMISED CONTROLLED TRIAL OF RECOMBINANT TISSUE PLASMINOGEN ACTIVATOR VERSUS UROKINASE IN THE TREATMENT OF ACUTE PULMONARY EMBOLISMThe Lancet, 1988
- ACUTE PULMONARY EMBOLISM TREATED WITH TISSUE PLASMINOGEN ACTIVATORThe Lancet, 1986
- Effects of a single bolus of urokinase in patients with life-threatening pulmonary emboli: a descriptive trial.Circulation, 1984
- Natural history of pulmonary embolismProgress in Cardiovascular Diseases, 1975
- Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary EmbolismBMJ, 1971